Evidence map›Paper›PMID 28205554›Full record

ArticleNature communications2017

The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies.

Zenggang Li, Andrei A Ivanov, Rina Su, Valentina Gonzalez-Pecchi, Qi Qi, Songlin Liu, Philip Webber, Elizabeth McMillan, Lauren Rusnak, Cau Pham and 14 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 133 papers.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 219 citations in OpenAlex.

  1. Target discovery and drug design in the era of artificial intelligence.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Neo-Cysteine Molecular Glues for Targeting Mutated SMAD4 Protein.Angewandte Chemie (International ed. in English) · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 2 countries.

Zenggang LiDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Andrei A IvanovDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Rina SuDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Valentina Gonzalez-PecchiDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Qi QiDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Songlin LiuDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Philip WebberDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Elizabeth McMillanDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75220, USA.
Lauren RusnakDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Cau PhamDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Xiaoqian ChenDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Xiulei MoDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Brian RevennaughDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Wei ZhouDepartment of Hematology &Medical Oncology, Emory University, Atlanta, Georgia 30322, USA.
Adam MarcusDepartment of Hematology &Medical Oncology, Emory University, Atlanta, Georgia 30322, USA.
Sahar HaratiDepartment of Biomedical Informatics, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Xiang ChenDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China.
Margaret A JohnsDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Michael A WhiteDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75220, USA.
Carlos MorenoWinship Cancer Institute, Emory University, Atlanta, Georgia 30322, USA.
Lee A D CooperWinship Cancer Institute, Emory University, Atlanta, Georgia 30322, USA.
Yuhong DuDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Fadlo R KhuriDepartment of Hematology &Medical Oncology, Emory University, Atlanta, Georgia 30322, USA.
Haian FuDepartment of Pharmacology and Emory Chemical Biology Discovery Center, Emory University, Atlanta, Georgia 30322, USA.
Emory University · USCentral South University · CNThe University of Texas Southwestern Medical Center · USHuazhong University of Science and Technology · CNXiangya Hospital Central South University · CN

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
Targeting Microtubules and HDAC6 in NSCLCP01CA116676 · NCI · EMORY UNIVERSITY · PI KHURI, FADLO RAJA · 2006 to 2012
$8.0M
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbationU01CA217875 · NCI · EMORY UNIVERSITY · PI FU, HAIAN · 2017 to 2021
$4.5M
HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION INTERROGATION IN CANCERU01CA168449 · NCI · EMORY UNIVERSITY · PI FU, HAIAN · 2012 to 2016
$4.2M
Lung cancer oncogenotype-selective drug target discoveryU01CA176284 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MACMILLAN, JOHN B, MINNA, JOHN D. · 2013 to 2016
$2.8M
Targeting Mechanistic Subtypes of Neoplastic DiseaseR35CA197717 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WHITE, MICHAEL A. · 2015 to 2015
$725k
NCI NIH HHS P01 CA116676NCI NIH HHS P30 CA138292NCI NIH HHS R35 CA197717NCI NIH HHS U01 CA168449NCI NIH HHS U01 CA176284NCI NIH HHS U01 CA217875
6 · The paper itself

Abstract

As genomics advances reveal the cancer gene landscape, a daunting task is to understand how these genes contribute to dysregulated oncogenic pathways. Integration of cancer genes into networks offers opportunities to reveal protein-protein interactions (PPIs) with functional and therapeutic significance. Here, we report the generation of a cancer-focused PPI network, termed OncoPPi, and identification of >260 cancer-associated PPIs not in other large-scale interactomes. PPI hubs reveal new regulatory mechanisms for cancer genes like MYC, STK11, RASSF1 and CDK4. As example, the NSD3 (WHSC1L1)-MYC interaction suggests a new mechanism for NSD3/BRD4 chromatin complex regulation of MYC-driven tumours. Association of undruggable tumour suppressors with drug targets informs therapeutic options. Based on OncoPPi-derived STK11-CDK4 connectivity, we observe enhanced sensitivity of STK11-silenced lung cancer cells to the FDA-approved CDK4 inhibitor palbociclib. OncoPPi is a focused PPI resource that links cancer genes into a signalling network for discovery of PPI targets and network-implicated tumour vulnerabilities for therapeutic interrogation.

Indexed as

AMP-Activated Protein Kinase KinasesBromodomain Containing ProteinsCell Cycle ProteinsCell Line, TumorCell SurvivalCyclin-Dependent Kinase 4Databases, ProteinGene Expression Regulation, NeoplasticGene Regulatory NetworksGenes, mycGenes, Tumor SuppressorGenomicsHistone-Lysine N-MethyltransferaseHumansLung NeoplasmsMolecular Targeted TherapyAMP-Activated Protein Kinase KinasesBRD4 protein, humanBromodomain Containing ProteinsCDK4 protein, humanCell Cycle ProteinsCyclin-Dependent Kinase 4Histone-Lysine N-MethyltransferaseNeoplasm ProteinsNSD3 protein, humanNuclear ProteinsProtein Kinase InhibitorsProtein Serine-Threonine KinasesRASSF1 protein, humanSTK11 protein, humanTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID28205554
PMCPMC5316855
OpenAlexW2588463727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.